Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size‐ADOIIAS

Morville, P; Akhavi, A.

doi:10.1002/ccd.27091

Cited by 58 publications

(59 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The total incidence of device embolization (3/30) was higher than previous series and was possibly exaggerated due to a small sample size and all of the cases performed at a single institution. The rate of LPA stenosis (1/30) was similar to Bruckheimer et al (2/60) and Morville and Akhavi (1/32) …”

Section: Discussionsupporting

confidence: 83%

“…The most common devices used for PDA closure are the Amplatzer Duct Occluder (ADO) I and the ADO II . The ADO II AS (additional sizes) is currently under trial in the United States, although it has been used successfully outside of the US for the last several years . The use of coils has decreased significantly over time, but with the introduction of Nit‐Occlud coils, their use may have increased somewhat .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: A multi‐institutional study

VanLoozen

Sandoval

Delaney

et al. 2018

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 83%

Section: Introductionmentioning

confidence: 99%

Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: A multi‐institutional study

VanLoozen

Sandoval

Delaney

et al. 2018

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…Success rate and major complications from transcatheter closure of PDA in preterm infants(43,49,50,52,(60)(61)(62).…”

mentioning

confidence: 99%

Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams

et al. 2020

View full text Add to dashboard Cite

Persistent patent ductus arteriosus (PDA) is very common in preterm infants, especially in extremely preterm infants. Despite significant advances in management of these vulnerable infants, there has been no consensus on management of PDA-when should we treat, who should we treat, how should we treat and in fact there is no agreement on how we should define a hemodynamically significant PDA. Medical management with non-steroidal anti-inflammatory drugs (NSAIDs) remains the first line of therapy with moderate success rate in closing the PDA. Paracetamol has been reported to be a safe and equally effective medical therapy for closure of PDA. However, additional studies on its long-term safety and efficacy in extremely low birth weight infants are needed before paracetamol can be recommended as standard treatment for a PDA in preterm infants. Surgical ligation of PDA is not without an increased risk of mortality and co-morbidities. Recently, there has been a significant interest in percutaneous transcatheter closure of PDA in preterm infants, including extremely low birth weight infants. Transcatheter PDA closure in preterm ELBW infants is technically feasible with high PDA occlusion success rates and acceptable complication rates as compared to surgical ligation. Many centers have reported promising early-and mid-term follow-up results. However, they need to be further tested in the prospective well-designed studies and randomized controlled trials comparing the results and outcomes of this technique with current treatment strategies including medical treatment before they can be used as the new standard of care for PDA closure in extremely low birth weight infants.

show abstract

“…Transcatheter closure of the persistently patent ductus arteriosus (PDA) in premature infants has been performed for over a decade . A device specifically designed for use to close the PDA in premature infants with a small (4F) delivery catheter was developed in piglets and used outside the United States . However, this device (Amplatzer Ductal Occluder II Additional Sizes—ADOII‐AS) is just in clinical trials in the US.…”

Section: Introductionmentioning

confidence: 99%

Echocardiographic imaging of the Medtronic Micro Vascular Plug^™ during off label placement in the premature infant with patent ductus arteriosus

et al. 2019

View full text Add to dashboard Cite

Objectives:To report the usefulness of harmonic imaging in echocardiography to visualize and direct the implantation of the Medtronic micro vascular plug (MVP).Background: Off label use of the MVP was reported for transcatheter occlusion of patent ductus arteriosus (PDA) in premature infants. The device is poorly visible on fluoroscopy and echocardiography. Methods:In 9 consecutive premature infants, the MVP was used for transcatheter closure of the PDA. In each, the ability of conventional echocardiographic imaging was compared to harmonic imaging, and the device was deployed in the PDA using echocardiography. Results:In each subject, harmonic imaging proved superior to conventional echocardiography to visualize the MVP in premature infants using 12 and 8 MHz probes.Once the delivery, catheter was across the PDA into the descending aorta, and the MVP advanced to the catheter tip, positioning, and deployment of the device was possible without fluoroscopy. All devices were deployed appropriately with immediate occlusion and no obstruction to the left pulmonary artery or aorta. Conclusions:The MVP can be accurately imaged using harmonic imaging, even in the near field in premature infants. Precise implantation of the MVP in the PDA of premature infants is possible with echocardiographic imaging of the device and vascular structures. K E Y W O R D Sechocardiographic imaging, patent ductus arteriosus, premature infants, transcatheter therapy | 945 BERRY Et al.Both reports of use of the MVP note that the device is not radioopaque with the exception of the brads that gather the wires of the nitinol frame. Echocardiographic 2-dimensional imaging has been difficult as the device is "challenging to visualize" and "not as visible by…echocardiography…as the Amplatzer devices" 5,6 ( Figure 2).

show abstract

Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size‐ADOIIAS

Abstract: It is feasible to close HSPDA in relative safety in premature infants who have severe and complex disease. Success requires perfect selection of the occluder and exact positioning by US. © 2017 Wiley Periodicals, Inc.

Cited by 58 publications

References 18 publications

Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: A multi‐institutional study

Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: A multi‐institutional study

Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams

Echocardiographic imaging of the Medtronic Micro Vascular Plug^™ during off label placement in the premature infant with patent ductus arteriosus

Contact Info

Product

Resources

About

Transcatheter closure of hemodynamic significant patent ductus arteriosus in 32 premature infants by amplatzer ductal occluder additional size‐ADOIIAS

Abstract: It is feasible to close HSPDA in relative safety in premature infants who have severe and complex disease. Success requires perfect selection of the occluder and exact positioning by US. © 2017 Wiley Periodicals, Inc.

Cited by 58 publications

References 18 publications

Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: A multi‐institutional study

Use of Amplatzer vascular plugs and Amplatzer duct occluder II additional sizes for occlusion of patent ductus arteriosus: A multi‐institutional study

Transcatheter Closure of Patent Ductus Arteriosus in Infants With Weight Under 1,500 Grams

Echocardiographic imaging of the Medtronic Micro Vascular Plug™ during off label placement in the premature infant with patent ductus arteriosus

Contact Info

Product

Resources

About

Echocardiographic imaging of the Medtronic Micro Vascular Plug^™ during off label placement in the premature infant with patent ductus arteriosus